• About us
• Contact

Advertisement

Product › Details

Lescol® XL

	Next higher product group	fluvastatin (INN)
	Status	1998-11-03 development start
	Organisation	Novartis Pharma AG
	Group	Novartis (Group)

Record changed: 2023-07-10

Advertisement

More documents for lipid-lowering drug

• [1] NewAmsterdam Pharma Company N.V.. (4/1/24). "Press Release: NewAmsterdam Pharma Announces the Appointment of Juliette Audet as Chief Business Officer". Naarden & Miami, FL....
• [2] NewAmsterdam Pharma Company N.V.. (2/13/24). "Press Release: NewAmsterdam Pharma Announces Commencement of Public Offering of Ordinary Shares and Pre-Funded Warrants". Naarden & Miami, FL....
• [3] NewAmsterdam Pharma Company N.V.. (2/13/24). "Press Release: NewAmsterdam Pharma Announces Pricing of $175.3 Million Public Offering of Ordinary Shares and Pre-Funded Warrants". Naarden & Miami, FL....
• [4] NewAmsterdam Pharma Holding B.V.. (7/25/22). "Press Release: NewAmsterdam Pharma Holding B.V. and Frazier Lifesciences Acquisition Corporation Announce Merger Agreement to Create Publicly Listed Company Focused on Oral Therapies for Cardiometabolic Disea...
• [5] NewAmsterdam Pharma B.V.. (6/28/22). "Press Release: NewAmsterdam Pharma and the Menarini Group Sign Licensing Deal to Commercialize Obicetrapib in Europe". Naarden, Miami, FL & Florence....
• [6] NewAmsterdam Pharma B.V.. (1/14/21). "Press Release: NewAmsterdam Pharma Completes $196M (€160M) Series A Funding for Comprehensive Phase 3 Development Program". Naarden....
• [7] NewAmsterdam Pharma B.V.. (8/25/20). "Press Release: NewAmsterdam Pharma Acquires Obicetrapib from Amgen". Naarden....
• [8] AstraZeneca plc. (2/2/17). "Press Release: Full-year and Q4 2016 Results"....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.